A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer
Clinical trial NCT03472365 · COMPLETED
Trial details
- NCT number
- NCT03472365
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-02
- Primary completion
- 2020-11-25
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.